107 related articles for article (PubMed ID: 38754569)
1. Investigation of crucial genes and mitochondrial function impairment in diabetic cardiomyopathy.
Tuersuntuoheti M; Zhou L; Li J; Yang S; Zhou S; Gong H
Gene; 2024 Sep; 923():148563. PubMed ID: 38754569
[TBL] [Abstract][Full Text] [Related]
2. Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy.
Li N; Wu H; Geng R; Tang Q
Dis Markers; 2018; 2018():6025061. PubMed ID: 30662576
[TBL] [Abstract][Full Text] [Related]
3. Grpel2 maintains cardiomyocyte survival in diabetic cardiomyopathy through DLST-mediated mitochondrial dysfunction: a proof-of-concept study.
Yang R; Zhang X; Zhang Y; Wang Y; Li M; Meng Y; Wang J; Wen X; Yu J; Chang P
J Transl Med; 2023 Mar; 21(1):200. PubMed ID: 36927450
[TBL] [Abstract][Full Text] [Related]
4. Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.
Su Q; Huang W; Huang Y; Dai R; Chang C; Li QY; Liu H; Li Z; Zhao Y; Wu Q; Pan DG
Cardiovasc Diabetol; 2024 Apr; 23(1):139. PubMed ID: 38664790
[TBL] [Abstract][Full Text] [Related]
5. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
Zhu N; Huang B; Zhu L; Wang Y
J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
[TBL] [Abstract][Full Text] [Related]
6. High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy.
Wu QR; Zheng DL; Liu PM; Yang H; Li LA; Kuang SJ; Lai YY; Rao F; Xue YM; Lin JJ; Liu SX; Chen CB; Deng CY
Cell Death Dis; 2021 Feb; 12(2):216. PubMed ID: 33637715
[TBL] [Abstract][Full Text] [Related]
7. HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress.
Chen D; Ruan X; Liu Y; He Y
Bioengineered; 2022 May; 13(5):11417-11429. PubMed ID: 35506308
[TBL] [Abstract][Full Text] [Related]
8. IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice.
Huang Q; Chen T; Li J; Wang Y; Shi H; Yu Y; Ji Q; Shen X; Sun T; Shi H; Luo X; Jin B; You Y; Wu B
J Transl Med; 2024 May; 22(1):494. PubMed ID: 38790051
[TBL] [Abstract][Full Text] [Related]
9. Weighted Gene Co-Expression Network Analysis Identifies ANGPTL4 as a Key Regulator in Diabetic Cardiomyopathy
Dai L; Xie Y; Zhang W; Zhong X; Wang M; Jiang H; He Z; Liu X; Zeng H; Wang H
Front Endocrinol (Lausanne); 2021; 12():705154. PubMed ID: 34616362
[TBL] [Abstract][Full Text] [Related]
10. CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction.
Guo P; Hu S; Liu X; He M; Li J; Ma T; Huang M; Fang Q; Wang Y
J Transl Med; 2024 Apr; 22(1):390. PubMed ID: 38671439
[TBL] [Abstract][Full Text] [Related]
11. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
[TBL] [Abstract][Full Text] [Related]
12. Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy.
Wang S; Zhao Z; Fan Y; Zhang M; Feng X; Lin J; Hu J; Cheng Z; Sun C; Liu T; Xiong Z; Yang Z; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1905-1914. PubMed ID: 29674007
[TBL] [Abstract][Full Text] [Related]
13. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
14. Potential molecular and cellular mechanisms of the effects of cuproptosis-related genes in the cardiomyocytes of patients with diabetic heart failure: a bioinformatics analysis.
Chen J; Yang X; Li W; Lin Y; Lin R; Cai X; Yan B; Xie B; Li J
Front Endocrinol (Lausanne); 2024; 15():1370387. PubMed ID: 38883603
[TBL] [Abstract][Full Text] [Related]
15. Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis.
Peng C; Zhang Y; Lang X; Zhang Y
J Transl Med; 2023 Feb; 21(1):66. PubMed ID: 36726122
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
18. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression.
Wang L; Bi X; Han J
IUBMB Life; 2020 Sep; 72(9):1997-2009. PubMed ID: 32734614
[TBL] [Abstract][Full Text] [Related]
19. LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy.
Zhang Q; Li D; Dong X; Zhang X; Liu J; Peng L; Meng B; Hua Q; Pei X; Zhao L; Hu X; Zhang Y; Pan Z; Lu Y; Yang B
Sci China Life Sci; 2022 Jun; 65(6):1198-1212. PubMed ID: 34668131
[TBL] [Abstract][Full Text] [Related]
20. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity.
Jin L; Geng L; Ying L; Shu L; Ye K; Yang R; Liu Y; Wang Y; Cai Y; Jiang X; Wang Q; Yan X; Liao B; Liu J; Duan F; Sweeney G; Woo CWH; Wang Y; Xia Z; Lian Q; Xu A
Circulation; 2022 Nov; 146(20):1537-1557. PubMed ID: 36134579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
